Tampa (Fla.) General Hospital has become the first health system in Florida to adopt the Liberty endovascular robotic system.
Liberty is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures, according to a Feb. 24 news release. The hospital’s adoption follows the device’s FDA 510(k) clearance and marks early post-clearance market activity.
About 2.5 million peripheral endovascular procedures are performed annually in the U.S., according to the release. Microbot Medical, developer of Liberty, began a limited market release in late 2025 and plans a full release at the Society of Interventional Radiology conference in April 2026.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.